Inventor
NARGUND RAVI P
US38 patents
⚠️ This page may combine multiple inventors who share the name “NARGUND RAVI P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
18 patentsUS5536716AJul 16, 1996
Spiro piperidines and homologs which promote release of growth hormone
MERCK & CO INC136 citations99
US6350760B1Feb 26, 2002
Substituted piperidines as melanocortin-4 receptor agonists
MERCK & CO INC102 citations97
US6410548B2Jun 25, 2002
Spiropiperidine derivatives as melanocortin receptor agonists
MERCK & CO INC71 citations96
US6294534B1Sep 25, 2001
Spiropiperidine derivatives as melanocortin receptor agonists
MERCK & CO INC75 citations96
US5652235AJul 29, 1997
Method of using spiro piperidines to promote the release of growth hormone
MERCK & CO INC67 citations96
US5578593ANov 26, 1996
Spiro piperidines and homologs promote release of growth hormone
MERCK & CO INC89 citations96
US6472398B1Oct 29, 2002
Spiropiperidine derivatives as melanocortin receptor agonists
MERCK & CO INC37 citations92
US6376509B2Apr 23, 2002
Melanocortin receptor agonists
MERCK & CO INC55 citations91
US6458790B2Oct 1, 2002
Substituted piperidines as melanocortin receptor agonists
MERCK & CO INC56 citations90
US7276520B2Oct 2, 2007
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC8 citations73
US6767915B2Jul 27, 2004
Substituted piperidines as melanocortin receptor agonists
MERCK & CO INC9 citations72
US7015235B2Mar 21, 2006
Acylated piperidine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC4 citations62
US7012084B2Mar 14, 2006
Acylated piperidine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC3 citations62
US7329673B2Feb 12, 2008
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC2 citations51
US7414057B2Aug 19, 2008
Piperazine urea derivatives as melanocortin-4 receptor agonists
MERCK & CO INC2 citations50
US7160886B2Jan 9, 2007
Acylated piperazine derivatives as melanocortin-4 receptor agonists
MERCK & CO INC1 citations50
US7618987B2Nov 17, 2009
Acylated piperidine derivatives as melanocortin 4-receptor agonists
MERCK & CO INC0 citations47
US7115628B2Oct 3, 2006
Bridged piperidine derivatives as melanocortin receptor agonists
MERCK & CO INC0 citations40
MERCK SHARP & DOHME
8 patentsUS9527875B2Dec 27, 2016
Antidiabetic tricyclic compounds
MERCK SHARP & DOHME4 citations71
US9834563B2Dec 5, 2017
Antidiabetic substituted heteroaryl compounds
MERCK SHARP & DOHME4 citations70
US7834042B2Nov 16, 2010
Angiotensin II receptor antagonists
MERCK SHARP & DOHME3 citations62
US7880014B2Feb 1, 2011
Angiotensin II receptor antagonists
MERCK SHARP & DOHME2 citations61
US9045467B2Jun 2, 2015
Oxazole derivatives useful as inhibitors of FAAH
MERCK SHARP & DOHME0 citations51
US7700778B2Apr 20, 2010
Acylated piperidine derivatives as melanocortin-4 receptor agonists
MERCK SHARP & DOHME0 citations51
US7652024B2Jan 26, 2010
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
MERCK SHARP & DOHME2 citations47
US10519115B2Dec 31, 2019
Antidiabetic tricyclic compounds
MERCK SHARP & DOHME0 citations39
CHEN DAVID
3 patentsUS8193228B2Jun 5, 2012
Substituted imidazole as bombesin receptor subtype-3 modulators
CHEN DAVID4 citations60
US8318767B2Nov 27, 2012
Substituted imidazoles as bombesin receptor subtype-3 modulators
CHEN DAVID0 citations50
US8106070B2Jan 31, 2012
Substituted imidazoles as bombesin receptor subtype-3 modulators
CHEN DAVID0 citations50